128 related articles for article (PubMed ID: 37902045)
1. Empirical Study on Exploring the Role of CD180 and MD-1 Prognostic Indicators for the Chronic Lymphocytic Leukaemia (CLL) Disease.
Alotaibi MA
Pak J Biol Sci; 2023 May; 26(6):311-320. PubMed ID: 37902045
[TBL] [Abstract][Full Text] [Related]
2. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
[TBL] [Abstract][Full Text] [Related]
3. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
[TBL] [Abstract][Full Text] [Related]
4. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
[TBL] [Abstract][Full Text] [Related]
6. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
[TBL] [Abstract][Full Text] [Related]
8. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
9. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
Stanganelli C; Travella A; Bezares R; Slavutsky I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
[TBL] [Abstract][Full Text] [Related]
11. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
[TBL] [Abstract][Full Text] [Related]
12. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
Ensafi AA; Amini M; Rezaei B; Talebi M
Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
[TBL] [Abstract][Full Text] [Related]
13. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
[TBL] [Abstract][Full Text] [Related]
14. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
[TBL] [Abstract][Full Text] [Related]
15. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.
Chen L; Zhang Y; Zheng W; Wu Y; Qiao C; Fan L; Xu W; Li J
Leuk Res; 2008 Oct; 32(10):1491-8. PubMed ID: 18359082
[TBL] [Abstract][Full Text] [Related]
16. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus JD; Chavez JC; Dalia S; Naqvi SMH; Talati C; Nodzon L; Kharfan-Dabaja MA; Pinilla-Ibarz J
Leuk Lymphoma; 2018 Jan; 59(1):59-68. PubMed ID: 28641468
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetics of chronic lymphocytic leukemia.
Patkar N; Rabade N; Kadam PA; Mishra F; Muranjan A; Tembhare P; Chaudhary S; Joshi S; Jain H; Dangi U; Bagal B; Khattry N; Menon H; Gujral S; Sengar M; Subramanian PG
Indian J Pathol Microbiol; 2017; 60(1):38-42. PubMed ID: 28195089
[TBL] [Abstract][Full Text] [Related]
18. Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
Avenarius MR; Huang Y; Hyak J; Byrd JC; Bhat SA; Grever M; Kittai AS; Rogers KA; Jones D; Zhao W; Heerema NA; Abruzzo LV; Woyach J; Miller CR
Hematol Oncol; 2023 Oct; 41(4):771-775. PubMed ID: 37010242
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the expression of CD32 and CD180 receptors on CLL cells and MEC1 cell line.
Tsertsvadze T; Mitskevich N; Ghirdaladze D; Porakishvili N
Georgian Med News; 2015 Mar; (240):56-9. PubMed ID: 25879560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]